Persimmune, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://persimmune.com
Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)
Phase 1
- Conditions
- Myelodysplastic Syndromes
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- PersImmune, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT03258359
- Locations
- 🇺🇸
University of California, San Diego, San Diego, California, United States
Collection of Samples From Patients With MDS
- Conditions
- Myelodysplastic Syndromes(MDS)
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- PersImmune, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT03072498
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸University of California San Diego, La Jolla, California, United States
Samples From Leukemia Patients and Their Donors to Identify Specific Antigens
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- PersImmune, Inc
- Target Recruit Count
- 50
- Registration Number
- NCT02667093
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
🇺🇸Northside Hospital, Atlanta, Georgia, United States